6.48
price down icon4.99%   -0.34
pre-market  Vorhandelsmarkt:  6.60   0.12   +1.85%
loading
Schlusskurs vom Vortag:
$6.82
Offen:
$6.82
24-Stunden-Volumen:
1.28M
Relative Volume:
0.44
Marktkapitalisierung:
$295.99M
Einnahmen:
$27.10M
Nettoeinkommen (Verlust:
$-24.31M
KGV:
-7.8072
EPS:
-0.83
Netto-Cashflow:
$-33.33M
1W Leistung:
-9.50%
1M Leistung:
-29.95%
6M Leistung:
-56.22%
1J Leistung:
+42.42%
1-Tages-Spanne:
Value
$6.26
$6.82
1-Wochen-Bereich:
Value
$6.19
$7.27
52-Wochen-Spanne:
Value
$3.52
$23.40

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Name
Firmenname
Capricor Therapeutics Inc
Name
Telefon
(310) 358-3200
Name
Adresse
8840 WILSHIRE BLVD, BEVERLY HILLS, CA
Name
Mitarbeiter
160
Name
Twitter
@Capricor
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
CAPR's Discussions on Twitter

Vergleichen Sie CAPR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CAPR
Capricor Therapeutics Inc
6.48 311.73M 27.10M -24.31M -33.33M -0.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-30 Eingeleitet Alliance Global Partners Buy
2025-06-26 Eingeleitet B. Riley Securities Buy
2025-05-20 Eingeleitet Roth Capital Buy
2024-10-21 Eingeleitet Piper Sandler Overweight
2024-05-17 Eingeleitet Oppenheimer Outperform
2024-01-05 Eingeleitet Cantor Fitzgerald Overweight
2022-10-26 Eingeleitet Ladenburg Thalmann Buy
2018-12-26 Herabstufung Maxim Group Buy → Hold
2018-01-26 Bestätigt H.C. Wainwright Buy
2017-09-15 Bestätigt H.C. Wainwright Buy
2017-02-13 Fortgesetzt Rodman & Renshaw Buy
2016-07-06 Fortgesetzt H.C. Wainwright Buy
2016-06-15 Eingeleitet ROTH Capital Buy
Alle ansehen

Capricor Therapeutics Inc Aktie (CAPR) Neueste Nachrichten

pulisher
Jul 24, 2025

Is Capricor Therapeutics Inc. a good long term investmentSignificant capital appreciation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Investors who lost money on Capricor Therapeutics, - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Arizona State Retirement System Buys Shares of 11,707 Capricor Therapeutics, Inc. (NASDAQ:CAPR) - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Shareholders that lost money on Capricor Therapeutics, Inc.(CAPR) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Barchart.com

Jul 24, 2025
pulisher
Jul 24, 2025

Recover Investment Losses: Levi & Korsinsky Files Class Action Against Capricor Therapeutics, Inc. (CAPR) - TradingView

Jul 24, 2025
pulisher
Jul 23, 2025

CAPRICOR THERAPEUTICS, INC. (NASDAQ:CAPR) DEADLINE ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - Morningstar

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Capricor Therapeutics Inc. stock priceOutperformance with explosive growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Capricor Therapeutics Inc. Stock Analysis and ForecastDouble-digit growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Eastern Progress

Jul 22, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCAPR - Business Wire

Jul 22, 2025
pulisher
Jul 22, 2025

Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc.CAPR - PR Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025CAPR - Morningstar

Jul 22, 2025
pulisher
Jul 22, 2025

Behind Capricor Therapeutics Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Capricor Therapeutics Inc. stockTriple-digit growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 15% loss last week hit both individual investors who own 47% as well as institutions - simplywall.st

Jul 22, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc. Securities Fraud Class Action - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

(CAPR) Technical Data - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 21, 2025

Securities Fraud and Market Volatility in Biotech: Lessons from Capricor's Downfall - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Rosen Law Firm Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

Investors Urged to Contact Levi & Korsinsky for Information Before September 15, 2025Capricor Therapeutics, Inc. (CAPR) - TradingView

Jul 21, 2025
pulisher
Jul 21, 2025

Important Notice to Long-Term Shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR); Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigatin - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Jul 21, 2025
pulisher
Jul 20, 2025

Class Action Lawsuit Filed: Capricor Therapeutics, Inc. (CAPR)Join by September 15, 2025Contact Levi & Korsinsky - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) Shareholders of Class Action Lawsuit and September 15, 2025 Deadline - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 20, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - StreetInsider

Jul 20, 2025
pulisher
Jul 20, 2025

CAPR ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Capricor Therapeutics, Inc.September 15, 2025 Deadline - ACCESS Newswire

Jul 20, 2025
pulisher
Jul 19, 2025

CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire

Jul 19, 2025
pulisher
Jul 19, 2025

CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) INVESTOR ALERT: - GlobeNewswire

Jul 19, 2025
pulisher
Jul 18, 2025

Investor Sues Biotech Capricor After Product's FDA Denial - Law360

Jul 18, 2025
pulisher
Jul 18, 2025

Levi & Korsinsky Urges Capricor Therapeutics, Inc. (CAPR) Shareholders to Act Before Lead Plaintiff Deadline September 15, 2025 - ACCESS Newswire

Jul 18, 2025
pulisher
Jul 18, 2025

Capricor Investor Sues After Disappointing FDA Return on Therapy - Bloomberg Law News

Jul 18, 2025
pulisher
Jul 18, 2025

Join Class Action to Recover Losses from Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky Before September 15, 2025 - TradingView

Jul 18, 2025
pulisher
Jul 18, 2025

CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Jul 18, 2025
pulisher
Jul 18, 2025

Will Capricor Therapeutics Inc. stock split in the near futureInvestor Favorite Picks - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - GlobeNewswire

Jul 18, 2025
pulisher
Jul 18, 2025

CAPR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc. Investors - TradingView

Jul 18, 2025
pulisher
Jul 18, 2025

Capricor’s Trial Data Deception Triggers Major Lawsuit - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Capricor Therapeutics Inc. stock outlookPrecision Entry Strategy - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Shareholders Filed a Lawsuit Against Capricor for Misleading Investors About FDA Approval - TradingView

Jul 18, 2025
pulisher
Jul 18, 2025

Capricor Therapeutics ($CAPR) Regulatory Misrepresentations and Stock Collapse Case - TradingView

Jul 18, 2025

Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):